Vita FertiBoost
Natural formula with all ingredients of proven efficacy to promote egg quality and ovarian Function Addressing Infertility and PCO.
Recently, numerous clinical studies have shown that the presence of several compounds in the follicular fluid positively correlates with oocyte quality and maturation improving ovarian stimulation protocols and pregnancy outcomes in infertile women with poor oocyte quality. (Myo-inositol, Folic Acid, melatonin, Coenzyme Q10, Vitamin E and Folic acid)
Further, Polycystic ovary syndrome (PCOS) is often characterized by chronic oligo- or anovulation (usually manifested as oligo- or amenorrhea), and hyperandrogenism. In addition, 30-40% of PCOS women have impaired glucose tolerance, and a defect in the insulin-signaling pathway.
(inositol-containing phosphoglycan mediators) is implicated in the pathogenesis of insulin resistance. PCOS patients are subfertile as a consequence of such ovulatory disorders and often need drugs, such as clomiphene citrate or follicle-stimulating hormone, for ovulation induction, which increases the risk of multiple pregnancy and ovarian hyperstimulation syndrome.
Clinical trials proven that the administration of an isoform of inositol (myo-inositol), the main ingredient of our product, Vita FertiBoost belonging to the vitamin B complex, improve the insulin-receptor activity, restoring normal ovulatory function.
Reference:
Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):555-61.
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Gynecol Endocrinol. 2011 Nov;27(11):857-61. doi: Epub 2011 Apr 5.
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study.
Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):555-61.
Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
Rizzo P1, Raffone E, Benedetto V.
Gynecol Endocrinol. 2012 Feb;28(2):91-3. doi: 10.3109/09513590.2011.589925. Epub 2011 Jul 20.
The efficacy of melatonin administration on oocyte quality.
Gynecol Endocrinol. 2007 Dec;23(12):700-3. Epub 2007 Oct 10.
Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
Eur Rev Med Pharmacol Sci. 2007 Sep-Oct;11(5):347-54.
Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
Eur Rev Med Pharmacol Sci. 2003 Nov-Dec;7(6):151-9.
Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):105-10.
Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
Gynecol Endocrinol. 2009 Aug;25(8):508-13. doi:
Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
Gynecol Endocrinol. 2008 Mar;24(3):139-44. doi: 10.1080/09513590801893232.
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome.
Aging Cell. 2015 Oct;14(5):887-95. doi: 10.1111/acel.12368. Epub 2015 Jun 26.
Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging.
Fertil Steril. 2009 Jul;92(1):328-43. doi: 10.1016/j.fertnstert.2008.05.016. Epub 2008 Sep 18.
Melatonin and the ovary: physiological and pathophysiological implications
Arch Gynecol Obstet. 2012 Apr;285(4):1173-6. doi: 10.1007/s00404-011-2169-2. Epub 2011 Dec 3.
Coenzyme Q10 content in follicular fluid and its relationship with oocyte fertilization and embryo grading.
J Assist Reprod Genet. 2012 Apr;29(4):325-8. doi: 10.1007/s10815-012-9714-1.
Vitamin E effect on controlled ovarian stimulation of unexplained infertile women.
The products and the claims made about specific products on or through this site have not been evaluated by Vita Range LLC. or the United States Food and Drug Administration and are not approved to diagnose, treat, cure or prevent disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.